Skip to main content
Article
4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis
RMD Open (2018)
  • Désirée van der Heijde, Leiden University Medical Center
  • Atul Deodhar, Oregon Health & Science University
  • Oliver FitzGerald, University College Dublin
  • Roy Fleischmann, University of Texas Southwestern Medical Center
  • Dafna Gladman, Toronto Western Hospital
  • Alice B Gottlieb, New York Medical College
  • Bengt Hoepken, UCB
  • Lars Bauer, UCB
  • Oscar Irvin-Sellers, UCB
  • Majed Khraishi, Memorial University of Newfoundland
  • Luke Peterson, UCB
  • Anthony Turkiewicz
  • Jürgen Wollenhaupt, Hochschule Hannover
  • Philip J Mease, University of Washington
Publication Date
March 1, 2018
DOI
10.1136/rmdopen-2017-000582
Citation Information
Désirée van der Heijde, Atul Deodhar, Oliver FitzGerald, Roy Fleischmann, et al.. "4-year results from the RAPID-PsA phase 3 randomised placebo-controlled trial of certolizumab pegol in psoriatic arthritis" RMD Open Vol. 4 Iss. 1 (2018)
Available at: http://works.bepress.com/philip-mease/17/